Applied Genetic Technologies Corporation (AGTC): Price and Financial Metrics


Applied Genetic Technologies Corporation (AGTC): $0.39

0.00 (1.23%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AGTC to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

AGTC POWR Grades

  • AGTC scores best on the Sentiment dimension, with a Sentiment rank ahead of 93.65% of US stocks.
  • AGTC's strongest trending metric is Stability; it's been moving up over the last 41 days.
  • AGTC's current lowest rank is in the Momentum metric (where it is better than 13.79% of US stocks).

AGTC Stock Summary

  • AGTC's price/sales ratio is 78.04; that's higher than the P/S ratio of 97.38% of US stocks.
  • As for revenue growth, note that AGTC's revenue has grown -35% over the past 12 months; that beats the revenue growth of just 5.6% of US companies in our set.
  • In terms of volatility of its share price, AGTC is more volatile than 96.13% of stocks we're observing.
  • Stocks that are quantitatively similar to AGTC, based on their financial statements, market capitalization, and price volatility, are TCRX, SYBX, TMDI, PULM, and MEIP.
  • Visit AGTC's SEC page to see the company's official filings. To visit the company's web site, go to www.agtc.com.

AGTC Valuation Summary

  • In comparison to the median Healthcare stock, AGTC's EV/EBIT ratio is 101.16% lower, now standing at -0.1.
  • Over the past 106 months, AGTC's price/earnings ratio has gone up 47.2.

Below are key valuation metrics over time for AGTC.

Stock Date P/S P/B P/E EV/EBIT
AGTC 2022-11-25 77.8 1.4 -0.4 -0.1
AGTC 2022-11-23 78.2 1.4 -0.4 -0.1
AGTC 2022-11-22 76.6 1.4 -0.4 -0.1
AGTC 2022-11-21 77.5 1.4 -0.4 -0.1
AGTC 2022-11-18 78.2 0.9 -0.4 0.0
AGTC 2022-11-17 78.2 0.9 -0.4 0.0

AGTC Growth Metrics

    The 3 year net income to common stockholders growth rate now stands at -3406.59%.
  • Its 5 year price growth rate is now at -29.84%.
  • Its 4 year net cashflow from operations growth rate is now at -26.21%.
Over the past 33 months, AGTC's revenue has gone down $23,852,000.

The table below shows AGTC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 0.325 -65.849 -70.234
2022-06-30 0.325 -65.748 -68.943
2022-03-31 0.5 -60.925 -62.693
2021-12-31 0.5 -58.358 -63.25
2021-09-30 0.5 -54.192 -59.568
2021-06-30 0.5 -51.173 -57.829

AGTC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AGTC has a Quality Grade of D, ranking ahead of 17.04% of graded US stocks.
  • AGTC's asset turnover comes in at 0.005 -- ranking 411th of 682 Pharmaceutical Products stocks.
  • HSTO, PLXP, and ABBV are the stocks whose asset turnover ratios are most correlated with AGTC.

The table below shows AGTC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.005 1 -1.382
2021-03-31 0.000 NA -1.146
2020-12-31 0.000 NA -1.079
2020-09-30 0.026 1 -0.945
2020-06-30 0.026 1 -0.842
2020-03-31 0.031 1 -0.796

AGTC Price Target

For more insight on analysts targets of AGTC, see our AGTC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $15.78 Average Broker Recommendation 1.33 (Strong Buy)

AGTC Stock Price Chart Interactive Chart >

Price chart for AGTC

AGTC Price/Volume Stats

Current price $0.39 52-week high $2.83
Prev. close $0.39 52-week low $0.23
Day low $0.37 Volume 764,500
Day high $0.40 Avg. volume 943,490
50-day MA $0.33 Dividend yield N/A
200-day MA $0.76 Market Cap 26.62M

Applied Genetic Technologies Corporation (AGTC) Company Bio


Applied Genetic Technologies is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed for patients with severe diseases in ophthalmology. The company was founded in 1999 and is based in Alachua, Florida.


AGTC Latest News Stream


Event/Time News Detail
Loading, please wait...

AGTC Latest Social Stream


Loading social stream, please wait...

View Full AGTC Social Stream

Latest AGTC News From Around the Web

Below are the latest news stories about APPLIED GENETIC TECHNOLOGIES CORP that investors may wish to consider to help them evaluate AGTC as an investment opportunity.

Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful completion of the previously announced tender offer (the “Offer”) to purchase all of the issued and outstanding shares of common stock of AGTC by a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”). The Offer, as extended, expired at 5:00 p.m., Eastern Time, on November 30, 2022, and the acquisition

Yahoo | December 1, 2022

Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”) has extended the expiration of its previously announced tender offer to purchase all of the issued and outstanding shares of AGTC common stock for $0.34 per share in cash at closing, plus up to an additional $0.73 per share payable pursuant to contingent valu

Yahoo | November 29, 2022

*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER*

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achievement of speci

Yahoo | November 28, 2022

*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *REMINDER*

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achievement of speci

Yahoo | November 22, 2022

Applied Genetic Technologies Corporation Urges Shareholders to Tender Their Shares by November 28, 2022

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, sent the following letter to stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achi

Yahoo | November 14, 2022

Read More 'AGTC' Stories Here

AGTC Price Returns

1-mo N/A
3-mo -2.84%
6-mo -5.18%
1-year -81.52%
3-year -93.17%
5-year -90.37%
YTD N/A
2022 0.00%
2021 -53.55%
2020 -9.51%
2019 81.53%
2018 -30.83%

Continue Researching AGTC

Want to see what other sources are saying about Applied Genetic Technologies Corp's financials and stock price? Try the links below:

Applied Genetic Technologies Corp (AGTC) Stock Price | Nasdaq
Applied Genetic Technologies Corp (AGTC) Stock Quote, History and News - Yahoo Finance
Applied Genetic Technologies Corp (AGTC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7003 seconds.